Mark Freitas’s articles from Alvarez & Marsal are most popular:
- within Food, Drugs, Healthcare and Life Sciences topic(s)
- in United States
- with readers working within the Pharmaceuticals & BioTech industries
Alvarez & Marsal are most popular:
- within Law Practice Management, Criminal Law, Litigation and Mediation & Arbitration topic(s)
With the FDA's disclosure of 200 Complete Response Letters (CRLs), leadership teams now have an unprecedented insight into regulatory decision-making to glean patterns, challenge assumptions, and strengthen governance before avoidable failures occur.
What You'll Learn
- How to anticipate avoidable risks in drug development, and why leadership is the key to preventing them.
- The surprising financial impact a single CRL can have on your market cap and approval timeline.
- The steps leaders must take to get ahead of the curve and outperform the market.
Three Harsh Realities
- CRLs trigger valuation hits, capital crunches, and risks strategic derailment.
- Reputations are on the line. Inaction fosters longer delays, deeper losses, and tougher recoveries, particularly for SMIDs.
- CRLs often stem from avoidable and preventable issues that can be tackled early on.
Turn Regulatory Adversity into Outperformance
- Institutionalize CRL risk. Make CRL analysis and planning a standing board item for SMIDs.
- Mobilize fast. Build cross-functional teams and playbooks ready to activate on trigger.
- Recalibrate capital. Invest early in critical CMC, manufacturing, and trial design to avoid costly fixes later downstream.
- Tighten oversight. Audit vendors, enforce accountability, reward quality, and own the risk.
- Leverage data to sharpen pipeline reviews, deal strategy, and risk assessments such as PTRS.
This disclosure is a wake-up call for the industry. Winning starts with knowing why others have lost. Get the insights to outperform the market today.
Originally published 27 October 2025
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
